<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37153597</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>09</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>06</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Long COVID: a review and proposed visualization of the complexity of long COVID.</ArticleTitle><Pagination><StartPage>1117464</StartPage><MedlinePgn>1117464</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1117464</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2023.1117464</ELocationID><Abstract><AbstractText>Post-Acute Sequelae of Severe Acute Respiratory Syndrome Coronavirus - 2 (SARS-CoV-2) infection, or Long COVID, is a prevailing second pandemic with nearly 100 million affected individuals globally and counting. We propose a visual description of the complexity of Long COVID and its pathogenesis that can be used by researchers, clinicians, and public health officials to guide the global effort toward an improved understanding of Long COVID and the eventual mechanism-based provision of care to afflicted patients. The proposed visualization or framework for Long COVID should be an evidence-based, dynamic, modular, and systems-level approach to the condition. Furthermore, with further research such a framework could establish the strength of the relationships between pre-existing conditions (or risk factors), biological mechanisms, and resulting clinical phenotypes and outcomes of Long COVID. Notwithstanding the significant contribution that disparities in access to care and social determinants of health have on outcomes and disease course of long COVID, our model focuses primarily on biological mechanisms. Accordingly, the proposed visualization sets out to guide scientific, clinical, and public health efforts to better understand and abrogate the health burden imposed by long COVID.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Perumal, Shunmugam, Naidoo, Abdool Karim, Wilkins, Garzino-Demo, Brechot, Parthasarathy, Vahlne and Nikolich.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Perumal</LastName><ForeName>Rubeshan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Centre for the AIDS Programme of Research in South Africa (CAPRISA), South African Medical Research Council (SAMRC) - CAPRISA HIV-TB Pathogenesis and Treatment Research Unit, Durban, South Africa.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pulmonology and Critical Care, Division of Internal Medicine, School Clinical Medicine, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Long COVID Taskforce, The Global Virus Network, Baltimore, MD, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shunmugam</LastName><ForeName>Letitia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Centre for the AIDS Programme of Research in South Africa (CAPRISA), South African Medical Research Council (SAMRC) - CAPRISA HIV-TB Pathogenesis and Treatment Research Unit, Durban, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naidoo</LastName><ForeName>Kogieleum</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Centre for the AIDS Programme of Research in South Africa (CAPRISA), South African Medical Research Council (SAMRC) - CAPRISA HIV-TB Pathogenesis and Treatment Research Unit, Durban, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdool Karim</LastName><ForeName>Salim S</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Centre for the AIDS Programme of Research in South Africa (CAPRISA), South African Medical Research Council (SAMRC) - CAPRISA HIV-TB Pathogenesis and Treatment Research Unit, Durban, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilkins</LastName><ForeName>Dave</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Long COVID Taskforce, The Global Virus Network, Baltimore, MD, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garzino-Demo</LastName><ForeName>Alfredo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Long COVID Taskforce, The Global Virus Network, Baltimore, MD, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Medicine, University of Padova, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brechot</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Long COVID Taskforce, The Global Virus Network, Baltimore, MD, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parthasarathy</LastName><ForeName>Sairam</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Allergy, Critical Care and Sleep Medicine and University of Arizona College of Medicine-Tucson, Tucson, AZ, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vahlne</LastName><ForeName>Anders</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Long COVID Taskforce, The Global Virus Network, Baltimore, MD, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Clinical Microbiology, Karolinska Institutet, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nikolich</LastName><ForeName>Janko &#x17d;</ForeName><Initials>J&#x17d;</Initials><AffiliationInfo><Affiliation>Long COVID Taskforce, The Global Virus Network, Baltimore, MD, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Immunobiology and the University of Arizona Center on Aging, University of Arizona College of Medicine-Tucson, Tucson, AZ, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Aegis Consortium for Pandemic-Free Future, University of Arizona Health Sciences, Tucson, AZ, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011634" MajorTopicYN="N">Public Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">long-haul COVID</Keyword><Keyword MajorTopicYN="N">post-acute sequelae of SARS-CoV-2</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>9</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>8</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>8</Day><Hour>4</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37153597</ArticleId><ArticleId IdType="pmc">PMC10157068</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1117464</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zollner A, Koch R, Jukic A, Pfister A, Meyer M, R&#xf6;ssler A, et al. . Postacute COVID-19 is characterized by gut viral antigen persistence in inflammatory bowel diseases. Gastroenterology (2022) 163(2):495&#x2013;506. doi:&#xa0;10.1053/j.gastro.2022.04.037</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2022.04.037</ArticleId><ArticleId IdType="pmc">PMC9057012</ArticleId><ArticleId IdType="pubmed">35508284</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review. J Infect Dis (2022) 226(9):1593&#x2013;607. doi:&#xa0;10.1093/infdis/jiac136</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo SM, Liu TC, Motwani Y, Sim MS, Viswanathan N, Samras N, et al. . Factors associated with post-acute sequelae of SARS-CoV-2 (PASC) after diagnosis of symptomatic COVID-19 in the inpatient and outpatient setting in a diverse cohort. J Gen Intern Med (2022) 2:1&#x2013;8. doi:&#xa0;10.1007/s11606-022-07523-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-022-07523-3</ArticleId><ArticleId IdType="pmc">PMC8989256</ArticleId><ArticleId IdType="pubmed">35391623</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat Med (2022) 28(7):1461&#x2013;7. doi:&#xa0;10.1038/s41591-022-01840-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenny G, McCann K, O&#x2019;Brien C, Savinelli S, Tinago W, Yousif O, et al. . Identification of distinct long COVID clinical phenotypes through cluster analysis of self-reported symptoms. Open Forum Infect Dis (2022) 9(4):ofac060. doi:&#xa0;10.1093/ofid/ofac060</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac060</ArticleId><ArticleId IdType="pmc">PMC8900926</ArticleId><ArticleId IdType="pubmed">35265728</ArticleId></ArticleIdList></Reference><Reference><Citation>Berry C, Mangion K. Multisystem involvement is common in post-COVID-19 syndrome. Nat Med (2022) 28(6):1139&#x2013;40. doi:&#xa0;10.1038/s41591-022-01838-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01838-8</ArticleId><ArticleId IdType="pmc">PMC9125959</ArticleId><ArticleId IdType="pubmed">35606552</ArticleId></ArticleIdList></Reference><Reference><Citation>Wise J. Covid-19: infection raises risk of diabetes and heart disease diagnoses in following weeks, study finds. BMJ (2022) 378:o1838. doi:&#xa0;10.1136/BMJ.O1838</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/BMJ.O1838</ArticleId><ArticleId IdType="pubmed">35868645</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Yu C, Jing H, Wu X, Novakovic VA, Xie R, et al. . Long COVID: the nature of thrombotic sequelae determines the necessity of early anticoagulation. Front Cell Infect Microbiol (2022) 12:861703/BIBTEX. doi:&#xa0;10.3389/FCIMB.2022.861703/BIBTEX</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FCIMB.2022.861703/BIBTEX</ArticleId><ArticleId IdType="pmc">PMC9016198</ArticleId><ArticleId IdType="pubmed">35449732</ArticleId></ArticleIdList></Reference><Reference><Citation>Natarajan A, Zlitni S, Brooks EF, Vance SE, Dahlen A, Hedlin H, et al. . Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection. Med (N Y) (2022) 3:371. doi:&#xa0;10.1016/J.MEDJ.2022.04.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.MEDJ.2022.04.001</ArticleId><ArticleId IdType="pmc">PMC9005383</ArticleId><ArticleId IdType="pubmed">35434682</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Yuan D, Chen DG, Ng RH, Wang K, Choi J, et al. . Multiple early factors anticipate post-acute COVID-19 sequelae. Cell (2022) 185:881&#x2013;95.e20. doi:&#xa0;10.1016/J.CELL.2022.01.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.CELL.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfaff ER, Girvin AT, Bennett TD, Bhatia A, Brooks IM, Deer RR, et al. . Identifying who has long COVID in the USA: a machine learning approach using N3C data. Lancet Digit Health (2022) 4:e532. doi:&#xa0;10.1016/S2589-7500(22)00048-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2589-7500(22)00048-6</ArticleId><ArticleId IdType="pmc">PMC9110014</ArticleId><ArticleId IdType="pubmed">35589549</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehandru S, Merad M. Pathological sequelae of long-haul COVID. Nat Immunol (2022) 23(2):194&#x2013;202. doi:&#xa0;10.1038/s41590-021-01104-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01104-y</ArticleId><ArticleId IdType="pmc">PMC9127978</ArticleId><ArticleId IdType="pubmed">35105985</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutler DM, Summers LH. The COVID-19 pandemic and the $16 trillion virus. JAMA (2020) 324:1495&#x2013;6. doi:&#xa0;10.1001/JAMA.2020.19759</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/JAMA.2020.19759</ArticleId><ArticleId IdType="pmc">PMC7604733</ArticleId><ArticleId IdType="pubmed">33044484</ArticleId></ArticleIdList></Reference><Reference><Citation>Choutka J, Jansari V, Hornig M, Iwasaki A. Unexplained post-acute infection syndromes. Nat Med (2022) 28(5):911&#x2013;23. doi:&#xa0;10.1038/s41591-022-01810-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01810-6</ArticleId><ArticleId IdType="pubmed">35585196</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. . Attributes and predictors of long COVID. Nat Med (2021) 27:626&#x2013;31. doi:&#xa0;10.1038/S41591-021-01292-Y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41591-021-01292-Y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran A. V.; misra, a. post COVID-19 syndrome (&#x201c;Long COVID&#x201d;) and diabetes: challenges in diagnosis and management. Diabetes Metab Syndr (2021) 15:102235. doi:&#xa0;10.1016/J.DSX.2021.102235</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.DSX.2021.102235</ArticleId><ArticleId IdType="pmc">PMC8317446</ArticleId><ArticleId IdType="pubmed">34384972</ArticleId></ArticleIdList></Reference><Reference><Citation>Yomogida K, Zhu S, Rubino F, Figueroa W, Balanji N, Holman E. Post-acute sequelae of SARS-CoV-2 infection among adults aged &#x2265;18 years &#x2014; long beach, California, April 1&#x2013;December 10, 2020. MMWR Morb Mortal Wkly Rep (2021) 70:1274&#x2013;7. doi:&#xa0;10.15585/MMWR.MM7037A2</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/MMWR.MM7037A2</ArticleId><ArticleId IdType="pmc">PMC8445372</ArticleId><ArticleId IdType="pubmed">34529639</ArticleId></ArticleIdList></Reference><Reference><Citation>Desgranges F, Tadini E, Munting A, Regina J, Filippidis P, Viala B, et al. . Post-COVID-19 syndrome in outpatients: a cohort study. J Gen Internal Med (2022) 2022:1&#x2013;10. doi:&#xa0;10.1007/S11606-021-07242-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S11606-021-07242-1</ArticleId><ArticleId IdType="pmc">PMC8939498</ArticleId><ArticleId IdType="pubmed">35319081</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlis RH, Green J, Santillana M, Lazer D, Ognyanova K, Simonson M, et al. . Persistence of symptoms up to 10 months following acute COVID-19 illness. medRxiv (2021) [Preprint]. doi:&#xa0;10.1101/2021.03.07.21253072</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.07.21253072</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin M, Schommers P, Stecher M, Dewald F, Gieselmann L, Gruell H, et al. . Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Regional Health - Europe (2021) 6:100122. doi:&#xa0;10.1016/J.LANEPE.2021.100122</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.LANEPE.2021.100122</ArticleId><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>Naik S, Haldar SN, Soneja M, Mundadan NG, Garg P, Mittal A, et al. . Post COVID-19 sequelae: a prospective observational study from northern India. Drug Discovery Ther (2021) 15:254&#x2013;60. doi:&#xa0;10.5582/DDT.2021.01093</Citation><ArticleIdList><ArticleId IdType="doi">10.5582/DDT.2021.01093</ArticleId><ArticleId IdType="pubmed">34719599</ArticleId></ArticleIdList></Reference><Reference><Citation>Matta J, Wiernik E, Robineau O, Carrat F, Touvier M, Severi G, et al. . Association of self-reported COVID-19 infection and SARS-CoV-2 serology test results with persistent physical symptoms among French adults during the COVID-19 pandemic. JAMA Intern Med (2022) 182:19&#x2013;25. doi:&#xa0;10.1001/JAMAINTERNMED.2021.6454</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/JAMAINTERNMED.2021.6454</ArticleId><ArticleId IdType="pmc">PMC8576624</ArticleId><ArticleId IdType="pubmed">34747982</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, Myles P, Williams T, Gokhale KM, et al. . Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med (2022) 28(8):1706&#x2013;14. doi:&#xa0;10.1038/s41591-022-01909-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold JE, Okyay RA, Licht WE, Hurley DJ. Investigation of long COVID prevalence and its relationship to Epstein-Barr virus reactivation. Pathogens (2021) 10(6):763. doi:&#xa0;10.3390/pathogens10060763</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens10060763</ArticleId><ArticleId IdType="pmc">PMC8233978</ArticleId><ArticleId IdType="pubmed">34204243</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed S, Jafri L, Hoodbhoy Z, Siddiqui I. Prognostic value of serum procalcitonin in COVID-19 patients: a systematic review. Indian J Crit Care Med (2021) 25:77. doi:&#xa0;10.5005/JP-JOURNALS-10071-23706</Citation><ArticleIdList><ArticleId IdType="doi">10.5005/JP-JOURNALS-10071-23706</ArticleId><ArticleId IdType="pmc">PMC7874291</ArticleId><ArticleId IdType="pubmed">33603306</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigfrid L, Drake TM, Pauley E, Jesudason EC, Olliaro P, Lim WS, et al. . Long covid in adults discharged from UK hospitals after covid-19: a prospective, multicentre cohort study using the ISARIC WHO clinical characterisation protocol. Lancet Regional Health - Europe (2021) 8:100186. doi:&#xa0;10.1016/J.LANEPE.2021.100186/ATTACHMENT/63F64C27-94C1-482F-A63F-48FE8972B440/MMC12.DOCX</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.LANEPE.2021.100186/ATTACHMENT/63F64C27-94C1-482F-A63F-48FE8972B440/MMC12.DOCX</ArticleId><ArticleId IdType="pmc">PMC8343377</ArticleId><ArticleId IdType="pubmed">34386785</ArticleId></ArticleIdList></Reference><Reference><Citation>Mollica V, Rizzo A, Massari F. The pivotal role of TMPRSS2 in coronavirus disease 2019 and prostate cancer. Future Oncol (2020) 16:2029&#x2013;33. doi:&#xa0;10.2217/FON-2020-0571</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/FON-2020-0571</ArticleId><ArticleId IdType="pmc">PMC7359420</ArticleId><ArticleId IdType="pubmed">32658591</ArticleId></ArticleIdList></Reference><Reference><Citation>Malkova A, Kudlay D, Kudryavtsev I, Starshinova A, Yablonskiy P, Shoenfeld Y, et al. . Immunogenetic predictors of severe covid-19. mdpi.com (2021) 9:211. doi:&#xa0;10.3390/vaccines9030211</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9030211</ArticleId><ArticleId IdType="pmc">PMC8001669</ArticleId><ArticleId IdType="pubmed">33802310</ArticleId></ArticleIdList></Reference><Reference><Citation>Taneja V. Sex hormones determine immune response. Front Immunol (2018) 9:1931/FULL. doi:&#xa0;10.3389/FIMMU.2018.01931/FULL</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FIMMU.2018.01931/FULL</ArticleId><ArticleId IdType="pmc">PMC6119719</ArticleId><ArticleId IdType="pubmed">30210492</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi T, Ellingson MK, Wong P, Israelow B, Lucas C, Klein J, et al. . Sex differences in immune responses that underlie COVID-19 disease outcomes. Nature (2020) 588(7837):315&#x2013;20. doi:&#xa0;10.1038/s41586-020-2700-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2700-3</ArticleId><ArticleId IdType="pmc">PMC7725931</ArticleId><ArticleId IdType="pubmed">32846427</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y, Li X, Geng D, Mei N, Wu PY, Huang CC, et al. . Cerebral micro-structural changes in COVID-19 patients &#x2013; an MRI-based 3-month follow-up study. EClinicalMedicine (2020) 25:100484. doi:&#xa0;10.1016/J.ECLINM.2020.100484</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.ECLINM.2020.100484</ArticleId><ArticleId IdType="pmc">PMC7396952</ArticleId><ArticleId IdType="pubmed">32838240</ArticleId></ArticleIdList></Reference><Reference><Citation>van den Borst B, Peters JB, Brink M, Schoon Y, Bleeker-Rovers CP, Schers H, et al. . Comprehensive health assessment 3 months after recovery from acute coronavirus disease 2019 (COVID-19). Clin Infect Dis (2021) 73:e1089. doi:&#xa0;10.1093/CID/CIAA1750</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/CID/CIAA1750</ArticleId><ArticleId IdType="pmc">PMC7717214</ArticleId><ArticleId IdType="pubmed">33220049</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Wang F, Shen Y, Zhang X, Cen Y, Wang B, et al. . Symptoms and health outcomes among survivors of COVID-19 infection 1 year after discharge from hospitals in wuhan, China. JAMA Netw Open (2021) 4:e2127403&#x2013;e2127403. doi:&#xa0;10.1001/JAMANETWORKOPEN.2021.27403</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/JAMANETWORKOPEN.2021.27403</ArticleId><ArticleId IdType="pmc">PMC8482055</ArticleId><ArticleId IdType="pubmed">34586367</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng F, Dai C, Cai P, Wang J, Xu L, Li J, et al. . Comparison study of SARS-CoV-2 IgG antibody between Male and female COVID-19 patients: a possible reason underlying different outcome between sex. J Med Virol (2020) 92:2050&#x2013;4. doi:&#xa0;10.1002/JMV.25989</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JMV.25989</ArticleId><ArticleId IdType="pmc">PMC7267228</ArticleId><ArticleId IdType="pubmed">32383183</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyerstedt S, Casaro EB, Rangel &#xc9;.B. COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection. Eur J Clin Microbiol Infect Dis (2021) 40:905. doi:&#xa0;10.1007/S10096-020-04138-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S10096-020-04138-6</ArticleId><ArticleId IdType="pmc">PMC7778857</ArticleId><ArticleId IdType="pubmed">33389262</ArticleId></ArticleIdList></Reference><Reference><Citation>Vrints CJM, Krychtiuk KA, van Craenenbroeck EM, Segers VF, Price S, Heidbuchel H. Endothelialitis plays a central role in the pathophysiology of severe COVID-19 and its cardiovascular complications. Acta Cardiol (2020) 76:1. doi:&#xa0;10.1080/00015385.2020.1846921</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00015385.2020.1846921</ArticleId><ArticleId IdType="pmc">PMC7682384</ArticleId><ArticleId IdType="pubmed">33208052</ArticleId></ArticleIdList></Reference><Reference><Citation>Voiriot G, Oualha M, Pierre A, Salmon-Gandonni&#xe8;re C, Gaudet A, Jouan Y, et al. . Chronic critical illness and post-intensive care syndrome: from pathophysiology to clinical challenges. Ann Intensive Care (2022) 12(1):1&#x2013;14. doi:&#xa0;10.1186/S13613-022-01038-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S13613-022-01038-0</ArticleId><ArticleId IdType="pmc">PMC9250584</ArticleId><ArticleId IdType="pubmed">35779142</ArticleId></ArticleIdList></Reference><Reference><Citation>Vrettou CS, Mantziou V, Vassiliou AG, Dimopoulou I, Orfanos SE, Kotanidou A. Post-intensive care syndrome in survivors from critical illness including COVID-19 patients: a narrative review. Life (Basel) (2022) 12(1):107. doi:&#xa0;10.3390/life12010107</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life12010107</ArticleId><ArticleId IdType="pmc">PMC8778667</ArticleId><ArticleId IdType="pubmed">35054500</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol (2016) 16(10):626&#x2013;38. doi:&#xa0;10.1038/nri.2016.90</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2016.90</ArticleId><ArticleId IdType="pubmed">27546235</ArticleId></ArticleIdList></Reference><Reference><Citation>Bajaj V, Gadi N, Spihlman AP, Wu SC, Choi CH, Moulton VR. Aging, immunity, and COVID-19: how age influences the host immune response to coronavirus infections? Front Physiol (2021) 11:571416/BIBTEX. doi:&#xa0;10.3389/FPHYS.2020.571416/BIBTEX</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FPHYS.2020.571416/BIBTEX</ArticleId><ArticleId IdType="pmc">PMC7835928</ArticleId><ArticleId IdType="pubmed">33510644</ArticleId></ArticleIdList></Reference><Reference><Citation>Spiering AE, de Vries TJ. Why females do better: the X chromosomal TLR7 gene-dose effect in COVID-19. Front Immunol (2021) 12:756262/BIBTEX. doi:&#xa0;10.3389/FIMMU.2021.756262/BIBTEX</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FIMMU.2021.756262/BIBTEX</ArticleId><ArticleId IdType="pmc">PMC8632002</ArticleId><ArticleId IdType="pubmed">34858409</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciarambino T, Para O, Giordano M. Immune system and COVID-19 by sex differences and age. Women&#x2019;s Health (2021) 17:17455065211022262. doi:&#xa0;10.1177/17455065211022262</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/17455065211022262</ArticleId><ArticleId IdType="pmc">PMC8188967</ArticleId><ArticleId IdType="pubmed">34096383</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Husinat L, Nusir M, Al-Gharaibeh H, Alomari AA, Smadi MM, Battaglini D, et al. . Post-COVID-19 syndrome symptoms after mild and moderate SARS-CoV-2 infection. Front Med (Lausanne) (2022) 9:1017257/BIBTEX. doi:&#xa0;10.3389/FMED.2022.1017257/BIBTEX</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FMED.2022.1017257/BIBTEX</ArticleId><ArticleId IdType="pmc">PMC9573938</ArticleId><ArticleId IdType="pubmed">36262270</ArticleId></ArticleIdList></Reference><Reference><Citation>Maglietta G, Diodati F, Puntoni M, Lazzarelli S, Marcomini B, Patrizi L, et al. . Prognostic factors for post-COVID-19 syndrome: a systematic review and meta-analysis. J Clin Med (2022) 11(6):1541. doi:&#xa0;10.3390/jcm11061541</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11061541</ArticleId><ArticleId IdType="pmc">PMC8948827</ArticleId><ArticleId IdType="pubmed">35329867</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson EJ, Williams DM, Walker AJ, Mitchell RE, Niedzwiedz CL, Yang TC, et al. . Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nat Commun (2022) 13(1):3528. doi: 10.1038/s41467-022-30836-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30836-0</ArticleId><ArticleId IdType="pmc">PMC9240035</ArticleId><ArticleId IdType="pubmed">35764621</ArticleId></ArticleIdList></Reference><Reference><Citation>Daitch V, Yelin D, Awwad M, Guaraldi G, Mili&#x107; J, Mussini C, et al. . Characteristics of long COVID among older adults: a cross-sectional study. Int J Infect Dis (2022) 125:287&#x2013;93. doi:&#xa0;10.1016/j.ijid.2022.09.035</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2022.09.035</ArticleId><ArticleId IdType="pubmed">36191820</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte KI, de Oliveira MHS, Peligro PJ, Velasco JV, Macaranas I, Ver AT, et al. . Age, sex and previous comorbidities as risk factors not associated with SARS-CoV-2 infection for long COVID-19: a systematic review and meta-analysis. J Clin Med (2022) 11(24):7314. doi:&#xa0;10.3390/JCM11247314</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/JCM11247314</ArticleId><ArticleId IdType="pmc">PMC9787827</ArticleId><ArticleId IdType="pubmed">36555931</ArticleId></ArticleIdList></Reference><Reference><Citation>Norredam M, Hayward S, Deal A, Agyemang C, Hargreaves S. Understanding and addressing long-COVID among migrants and ethnic minorities in Europe. Lancet Regional Health - Europe (2022) 19. doi:&#xa0;10.1016/j.lanepe.2022.100427</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2022.100427</ArticleId><ArticleId IdType="pmc">PMC9241826</ArticleId><ArticleId IdType="pubmed">35789882</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeberg H, P&#xe4;&#xe4;bo S. The major genetic risk factor for severe COVID-19 is inherited from neanderthals. Nature (2020) 587(7835):610&#x2013;2. doi:&#xa0;10.1038/s41586-020-2818-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2818-3</ArticleId><ArticleId IdType="pubmed">32998156</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeberg H, P&#xe4;&#xe4;bo SA. Genomic region associated with protection against severe COVID-19 is inherited from neandertals. Proc Natl Acad Sci U.S.A. (2021) 118:e2026309118. doi:&#xa0;10.1073/PNAS.2026309118/SUPPL_FILE/PNAS.2026309118.SAPP.PDF</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/PNAS.2026309118/SUPPL_FILE/PNAS.2026309118.SAPP.PDF</ArticleId><ArticleId IdType="pmc">PMC7936282</ArticleId><ArticleId IdType="pubmed">33593941</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi UY, Kang JS, Hwang YS, Kim YJ. Oligoadenylate synthase-like (OASL) proteins: dual functions and associations with diseases. Exp Mol Med (2015) 47(3):e144&#x2013;4. doi:&#xa0;10.1038/emm.2014.110</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emm.2014.110</ArticleId><ArticleId IdType="pmc">PMC4351405</ArticleId><ArticleId IdType="pubmed">25744296</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinetti T, Hirzel C, Fux M, Walti LN, Schober P, Stueber F, et al. . Reduced monocytic human leukocyte antigen-DR expression indicates immunosuppression in critically ill COVID-19 patients. Anesth Analg (2020) 131:993. doi:&#xa0;10.1213/ANE.0000000000005044</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000005044</ArticleId><ArticleId IdType="pmc">PMC7288784</ArticleId><ArticleId IdType="pubmed">32925314</ArticleId></ArticleIdList></Reference><Reference><Citation>Iturrieta-Zuazo I, Rita CG, Garc&#xed;a-Soid&#xe1;n A, de Malet Pintos-Fonseca A, Alonso-Alarc&#xf3;n N, Pariente-Rodr&#xed;guez R, et al. . Possible role of HLA class-I genotype in SARS-CoV-2 infection and progression: a pilot study in a cohort of covid-19 Spanish patients. Clin Immunol (2020) 219:108572. doi:&#xa0;10.1016/J.CLIM.2020.108572</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.CLIM.2020.108572</ArticleId><ArticleId IdType="pmc">PMC7428760</ArticleId><ArticleId IdType="pubmed">32810602</ArticleId></ArticleIdList></Reference><Reference><Citation>Truong TT, Ryutov A, Pandey U, Yee R, Goldberg L, Bhojwani D, et al. . Increased viral variants in children and young adults with impaired humoral immunity and persistent SARS-CoV-2 infection: A consecutive case series. EBioMedicine (2021) 67:103355. doi:&#xa0;10.1016/j.ebiom.2021.103355</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103355</ArticleId><ArticleId IdType="pmc">PMC8072072</ArticleId><ArticleId IdType="pubmed">33915337</ArticleId></ArticleIdList></Reference><Reference><Citation>Altuntas Aydin O, Kumbasar Karaosmanoglu H, Kart Yasar K. HIV/SARS-CoV-2 coinfected patients in Istanbul, Turkey. J Med Virol (2020) 92:2288&#x2013;90. doi:&#xa0;10.1002/JMV.25955</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JMV.25955</ArticleId><ArticleId IdType="pubmed">32347975</ArticleId></ArticleIdList></Reference><Reference><Citation>Devresse A, de Greef J, Yombi JC, Belkhir L, Goffin E, Kanaan N. Immunosuppression and SARS-CoV-2 infection in kidney transplant recipients. Transplant Direct (2022) 8:E1292. doi:&#xa0;10.1097/TXD.0000000000001292</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TXD.0000000000001292</ArticleId><ArticleId IdType="pmc">PMC8843373</ArticleId><ArticleId IdType="pubmed">35187216</ArticleId></ArticleIdList></Reference><Reference><Citation>Pujari S, Gaikwad S, Chitalikar A, Dabhade D, Joshi K, Bele V. Long-coronavirus disease among people living with HIV in Western India: an observational study. Immun Inflammation Dis (2021) 9:1037. doi:&#xa0;10.1002/IID3.467</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/IID3.467</ArticleId><ArticleId IdType="pmc">PMC8239760</ArticleId><ArticleId IdType="pubmed">34078004</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Vlok M, Venter C, Bezuidenhout JA, Laubscher GJ, Steenkamp J, et al. . Persistent clotting protein pathology in long COVID/Post-acute sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc Diabetol (2021) 20(1):1&#x2013;8. doi:&#xa0;10.1186/S12933-021-01359-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S12933-021-01359-7</ArticleId><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Deveau T-M, Munter SE, Ryder D, Buck A, Beck-Engeser G, et al. . Chronic viral coinfections differentially affect the likelihood of developing long COVID. Journal of Clinical Investigation. (2023). 133(3):1&#x2013;1. doi:&#xa0;10.1172/JCI163669</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI163669</ArticleId><ArticleId IdType="pmc">PMC9888380</ArticleId><ArticleId IdType="pubmed">36454631</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervia C, Zurbuchen Y, Taeschler P, Ballouz T, Menges D, Hasler S, et al. . Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome. Nat Commun (2022) 13(1):1&#x2013;2. doi:&#xa0;10.1038/S41467-021-27797-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41467-021-27797-1</ArticleId><ArticleId IdType="pmc">PMC8789854</ArticleId><ArticleId IdType="pubmed">35078982</ArticleId></ArticleIdList></Reference><Reference><Citation>Herman JD, Atyeo C, Zur Y, Cook CE, Patel NJ, Vanni KM, et al. . Impact of cross-coronavirus immunity in post-acute sequelae of COVID-19. medRxiv [Preprint] (2022). doi:&#xa0;10.1101/2022.09.25.22280335</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.09.25.22280335</ArticleId></ArticleIdList></Reference><Reference><Citation>Philip KEJ, Buttery S, Williams P, Vijayakumar B, Tonkin J, Cumella A, et al. . Impact of COVID-19 on people with asthma: a mixed methods analysis from a UK wide survey. BMJ Open Respir Res (2022) 9:e001056. doi:&#xa0;10.1136/BMJRESP-2021-001056</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/BMJRESP-2021-001056</ArticleId><ArticleId IdType="pmc">PMC8762134</ArticleId><ArticleId IdType="pubmed">35027428</ArticleId></ArticleIdList></Reference><Reference><Citation>Aminian A, Bena J, Pantalone KM, Burguera B. Association of obesity with postacute sequelae of COVID-19. Diabetes Obes Metab (2021) 23:2183&#x2013;8. doi:&#xa0;10.1111/DOM.14454</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/DOM.14454</ArticleId><ArticleId IdType="pmc">PMC8239834</ArticleId><ArticleId IdType="pubmed">34060194</ArticleId></ArticleIdList></Reference><Reference><Citation>Debskiid M, Tsampasianid V, Haney S, Blakely K, Weston S, Ntatsaki E, et al. . Post-COVID-19 syndrome risk factors and further use of health services in East England. PloS Global Public Health (2022) 2:e0001188. doi:&#xa0;10.1371/JOURNAL.PGPH.0001188</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/JOURNAL.PGPH.0001188</ArticleId><ArticleId IdType="pmc">PMC10022108</ArticleId><ArticleId IdType="pubmed">36962824</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Quan L, Chavarro JE, Slopen N, Kubzansky LD, Karestan KC, et al. . Associations of depression, anxiety, worry, perceived stress, and loneliness prior to infection with risk of post&#x2013;COVID-19 conditions. JAMA Psychiatry (2022) 79(11):1081&#x2013;91. doi:&#xa0;10.1001/jamapsychiatry.2022.2640</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2022.2640</ArticleId><ArticleId IdType="pmc">PMC9453634</ArticleId><ArticleId IdType="pubmed">36069885</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C, Torres-Macho J, Velasco-Arribas M, Plaza-Canteli S, Arias-Naval&#xf3;n JA, Hern&#xe1;ndez-Barrera V, et al. . Preexisting hypertension is associated with a greater number of long-term post-COVID symptoms and poor sleep quality: a case&#x2013;control study. J Hum Hypertension (2022) 36(6):582&#x2013;4. doi:&#xa0;10.1038/s41371-022-00660-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41371-022-00660-6</ArticleId><ArticleId IdType="pmc">PMC8853057</ArticleId><ArticleId IdType="pubmed">35173268</ArticleId></ArticleIdList></Reference><Reference><Citation>Swank Z, Senussi Y, Manickas-Hill Z, Yu XG, Li JZ, Alter G, et al. . Persistent circulating severe acute respiratory syndrome coronavirus 2 spike is associated with post-acute coronavirus disease 2019 sequelae. Clin Infect Dis (2023) 76(3):e487&#x2013;90. doi:&#xa0;10.1093/cid/ciac722</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac722</ArticleId><ArticleId IdType="pmc">PMC10169416</ArticleId><ArticleId IdType="pubmed">36052466</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung CCL, Goh D, Lim X, Tien TZ, Lim JCT, Lee JN, et al. . Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19. Gut (2022) 71:226&#x2013;9. doi:&#xa0;10.1136/gutjnl-2021-324570</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-324570</ArticleId><ArticleId IdType="pubmed">34083386</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodin P, Casari G, Townsend L, O&#x2019;Farrelly C, Tancevski I, L&#xf6;ffler-Ragg J, et al. . Studying severe long COVID to understand post-infectious disorders beyond COVID-19. Nat Med (2022) 28(5):879&#x2013;82. doi:&#xa0;10.1038/s41591-022-01766-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01766-7</ArticleId><ArticleId IdType="pubmed">35383311</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs JJL. Persistent SARS-2 infections contribute to long COVID-19. Med Hypotheses (2021) 149:110538. doi:&#xa0;10.1016/J.MEHY.2021.110538</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.MEHY.2021.110538</ArticleId><ArticleId IdType="pmc">PMC7884250</ArticleId><ArticleId IdType="pubmed">33621843</ArticleId></ArticleIdList></Reference><Reference><Citation>Gal&#xe1;n M, Vig&#xf3;n L, Fuertes D, Murciano-Ant&#xf3;n MA, Casado-Fern&#xe1;ndez G, Dom&#xed;nguez-Mateos S, et al. . Persistent overactive cytotoxic immune response in a Spanish cohort of individuals with long-COVID: identification of diagnostic biomarkers. Front Immunol (2022) 13:848886/BIBTEX. doi:&#xa0;10.3389/FIMMU.2022.848886/BIBTEX</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FIMMU.2022.848886/BIBTEX</ArticleId><ArticleId IdType="pmc">PMC8990790</ArticleId><ArticleId IdType="pubmed">35401523</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas M, Rodr&#xed;guez Y, Acosta-Ampudia Y, Monsalve DM, Zhu C, Li Q-Z, et al. . Autoimmunity is a hallmark of post-COVID syndrome. J Transl Med (2022) 20:129. doi:&#xa0;10.1186/s12967-022-03328-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03328-4</ArticleId><ArticleId IdType="pmc">PMC8924736</ArticleId><ArticleId IdType="pubmed">35296346</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodruff MC, Ramonell RP, Haddad NS, Anam FA, Rudolph ME, Walker TA, et al. . Dysregulated naive b cells and de Novo autoreactivity in severe COVID-19. Nature (2022) 611(7934):139&#x2013;47. doi:&#xa0;10.1038/s41586-022-05273-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05273-0</ArticleId><ArticleId IdType="pmc">PMC9630115</ArticleId><ArticleId IdType="pubmed">36044993</ArticleId></ArticleIdList></Reference><Reference><Citation>Sacchi MC, Tamiazzo S, Stobbione P, Agatea L, de Gaspari P, Stecca A, et al. . SARS-CoV-2 infection as a trigger of autoimmune response. Clin Transl Sci (2021) 14:898&#x2013;907. doi:&#xa0;10.1111/CTS.12953</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/CTS.12953</ArticleId><ArticleId IdType="pmc">PMC8212749</ArticleId><ArticleId IdType="pubmed">33306235</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein J, Wood J, Jaycox J, Lu P, Dhodapkar RM, Gehlhausen JR, et al. . Distinguishing features of long COVID identified through immune profiling. medRxiv [Preprint] (2022). doi:&#xa0;10.1101/2022.08.09.22278592</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.08.09.22278592</ArticleId><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Page MJ, Engelbrecht L, Ellis GC, Kell DB. Substantial fibrin amyloidogenesis in type 2 diabetes assessed using amyloid-selective fluorescent stains. Cardiovasc Diabetol (2017) 16:1&#x2013;4. doi:&#xa0;10.1186/S12933-017-0624-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S12933-017-0624-5</ArticleId><ArticleId IdType="pmc">PMC5668975</ArticleId><ArticleId IdType="pubmed">29096623</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Venter C, Jacobus G, Mediclinic L, Maritha S, Kotze J, et al. . Prevalence of symptoms, comorbidities, brin amyloid microclots and platelet pathology in individuals with long COVID/ post-acute sequelae of COVID-19 (PASC). Cardiovasc Diabetol (2022) 21(1):148. doi:&#xa0;10.21203/rs.3.rs-1205453/v2</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-1205453/v2</ArticleId><ArticleId IdType="pmc">PMC9356426</ArticleId><ArticleId IdType="pubmed">35933347</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Venter C, Laubscher GJ, Kotze MJ, Moremi K, Oladejo S, et al. . Combined triple treatment of fibrin amyloid microclots and platelet pathology in individuals with long COVID/ post-acute sequelae of COVID-19 (PASC) can resolve their persistent symptoms. Research Square (2021). Preprint. doi:&#xa0;10.21203/RS.3.RS-1205453/V1</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/RS.3.RS-1205453/V1</ArticleId></ArticleIdList></Reference><Reference><Citation>Almutairi MM, Sivandzade F, Albekairi TH, Alqahtani F, Cucullo L. Neuroinflammation and its impact on the pathogenesis of COVID-19. Front Med (Lausanne) (2021) 8:745789. doi:&#xa0;10.3389/FMED.2021.745789</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FMED.2021.745789</ArticleId><ArticleId IdType="pmc">PMC8652056</ArticleId><ArticleId IdType="pubmed">34901061</ArticleId></ArticleIdList></Reference><Reference><Citation>Malkova A, Kudryavtsev I, Starshinova A, Kudlay D, Zinchenko Y, Glushkova A, et al. . Post COVID-19 syndrome in patients with Asymptomatic/Mild form. Pathogens (2021) 10(11):1408. doi:&#xa0;10.3390/pathogens10111408</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens10111408</ArticleId><ArticleId IdType="pmc">PMC8620929</ArticleId><ArticleId IdType="pubmed">34832564</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampshire A, Trender W, Chamberlain SR, Jolly AE, Grant JE, Patrick F, et al. . Cognitive deficits in people who have recovered from COVID-19. EClinicalMedicine (2021) 39:101044. doi:&#xa0;10.1016/J.ECLINM.2021.101044/ATTACHMENT/0675FA72-7493-4A17-AA19-4AD85BEB1BF0/MMC2.DOCX</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.ECLINM.2021.101044/ATTACHMENT/0675FA72-7493-4A17-AA19-4AD85BEB1BF0/MMC2.DOCX</ArticleId><ArticleId IdType="pmc">PMC8298139</ArticleId><ArticleId IdType="pubmed">34316551</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Persistent brainstem dysfunction in long-COVID: a. ACS Chem Neurosci (2021) 12:573. doi:&#xa0;10.1021/ACSCHEMNEURO.0C00793</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ACSCHEMNEURO.0C00793</ArticleId><ArticleId IdType="pubmed">33538586</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukiw WJ, Pogue A, Hill JM. SARS-CoV-2 infectivity and neurological targets in the brain. Cell Mol Neurobiol (2022) 42:217. doi:&#xa0;10.1007/S10571-020-00947-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S10571-020-00947-7</ArticleId><ArticleId IdType="pmc">PMC7445393</ArticleId><ArticleId IdType="pubmed">32840758</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekdahl KN, Teramura Y, Asif S, Jonsson N, Magnusson PU, Nilsson B. Thromboinflammation in therapeutic medicine. Adv Exp Med Biol (2015) 865:3&#x2013;17. doi:&#xa0;10.1007/978-3-319-18603-0_1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-319-18603-0_1</ArticleId><ArticleId IdType="pubmed">26306440</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal AD, VanElzakker MB. Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front Microbiol (2021) 12:698169/BIBTEX. doi:&#xa0;10.3389/FMICB.2021.698169/BIBTEX</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FMICB.2021.698169/BIBTEX</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen W, Pan JY. Anatomical and pathological observation and analysis of SARS and COVID-19: microthrombosis is the main cause of death. Biol Proced Online (2021) 23:1&#x2013;12. doi:&#xa0;10.1186/S12575-021-00142-Y/METRICS</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S12575-021-00142-Y/METRICS</ArticleId><ArticleId IdType="pmc">PMC7816139</ArticleId><ArticleId IdType="pubmed">33472576</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z, Flammer A, Steiger P, Lancet MH-T. Endothelial cell infection and endotheliitis in COVID-19. Lancet (2020) 395(10234):1417&#x2013;18. doi: 10.1016/S0140-6736(20)30937-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30937-5</ArticleId><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Song W, FitzGerald G. COVID-19, microangiopathy, hemostatic activation, and complement. Am Soc Clin Investig (2020) 130(8):3950&#x2013;3. doi: 10.1172/JCI140183</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI140183</ArticleId><ArticleId IdType="pmc">PMC7410042</ArticleId><ArticleId IdType="pubmed">32459663</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishiga M, Wang D, Han Y, L. D. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. nature (2020) 17(9):543&#x2013;58. doi: 10.1038/s41569-020-0413-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-020-0413-9</ArticleId><ArticleId IdType="pmc">PMC7370876</ArticleId><ArticleId IdType="pubmed">32690910</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung MK, Zidar DA, Bristow MR, Cameron SJ, Chan T, Harding C, et al. . COVID-19 and cardiovascular disease: from bench to bedside. Am Heart Assoc (2021) 128:1214&#x2013;36. doi:&#xa0;10.1161/CIRCRESAHA.121.317997</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.121.317997</ArticleId><ArticleId IdType="pmc">PMC8048382</ArticleId><ArticleId IdType="pubmed">33856918</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med (2022) 28(3):583&#x2013;90. doi:&#xa0;10.1038/s41591-022-01689-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Katwa LC, Mendoza C, Clements M. CVD and COVID-19: emerging roles of cardiac fibroblasts and myofibroblasts. Cells (2022) 11:1316. doi:&#xa0;10.3390/CELLS11081316</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/CELLS11081316</ArticleId><ArticleId IdType="pmc">PMC9031661</ArticleId><ArticleId IdType="pubmed">35455995</ArticleId></ArticleIdList></Reference><Reference><Citation>Guler SA, Ebner L, Aubry-Beigelman C, Bridevaux PO, Brutsche M, Clarenbach C, et al. . Pulmonary function and radiological features 4 months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study. Eur Respir J (2021) 57(4). doi:&#xa0;10.1183/13993003.03690-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03690-2020</ArticleId><ArticleId IdType="pmc">PMC8082329</ArticleId><ArticleId IdType="pubmed">33419891</ArticleId></ArticleIdList></Reference><Reference><Citation>Rai DK, Sharma P, Kumar R. Post covid 19 pulmonary fibrosis. is it real threat? Indian J Tuberculosis (2021) 68:330&#x2013;3. doi:&#xa0;10.1016/J.IJTB.2020.11.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.IJTB.2020.11.003</ArticleId><ArticleId IdType="pmc">PMC7654356</ArticleId><ArticleId IdType="pubmed">34099197</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali RMM, Ghonimy MBI. Post-COVID-19 pneumonia lung fibrosis: a worrisome sequelae in surviving patients. Egyptian J Radiol Nucl Med (2021) 52:1&#x2013;8. doi:&#xa0;10.1186/S43055-021-00484-3/FIGURES/8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S43055-021-00484-3/FIGURES/8</ArticleId></ArticleIdList></Reference><Reference><Citation>Saadat S, Noureddini M, Mahjoubin-Tehran M, Nazemi S, Shojaie L, Aschner M, et al. . Pivotal role of TGF-&#x3b2;/Smad signaling in cardiac fibrosis: non-coding RNAs as effectual players. Front Cardiovasc Med (2020) 7:588347. doi:&#xa0;10.3389/FCVM.2020.588347</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FCVM.2020.588347</ArticleId><ArticleId IdType="pmc">PMC7868343</ArticleId><ArticleId IdType="pubmed">33569393</ArticleId></ArticleIdList></Reference><Reference><Citation>Zatterale F, Longo M, Naderi J, Raciti GA, Desiderio A, Miele C, et al. . Chronic adipose tissue inflammation linking obesity to insulin resistance and type 2 diabetes. Front Physiol (2020) 10:1607/BIBTEX. doi:&#xa0;10.3389/FPHYS.2019.01607/BIBTEX</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FPHYS.2019.01607/BIBTEX</ArticleId><ArticleId IdType="pmc">PMC7000657</ArticleId><ArticleId IdType="pubmed">32063863</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B, Bluemke DA, L&#xfc;scher TF, Neubauer S. Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus. Eur Heart J (2022) 43:1157. doi:&#xa0;10.1093/EURHEARTJ/EHAC031</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/EURHEARTJ/EHAC031</ArticleId><ArticleId IdType="pmc">PMC8903393</ArticleId><ArticleId IdType="pubmed">35176758</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Deveau T-M, Munter SE, Ryder DM, Buck AM, Beck-Engeser G, et al. . Chronic viral coinfections differentially affect the likelihood of developing long COVID. J Clin Invest (2023) 133(3):1&#x2013;11. doi:&#xa0;10.1172/JCI163669</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI163669</ArticleId><ArticleId IdType="pmc">PMC9888380</ArticleId><ArticleId IdType="pubmed">36454631</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohrhofer J, Graninger M, Lettenmaier L, Schweighardt J, Gentile SA, Koidl L, et al. . Association between Epstein-Barr-Virus reactivation and development of long-COVID fatigue. Allergy (2023) 78:297&#x2013;9. doi:&#xa0;10.1111/ALL.15471</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ALL.15471</ArticleId><ArticleId IdType="pmc">PMC9538037</ArticleId><ArticleId IdType="pubmed">35950630</ArticleId></ArticleIdList></Reference><Reference><Citation>Apostolou E, Rizwan M, Moustardas P, Sj&#xf6;gren P, Bertilson BC, Brag&#xe9;e B, et al. . Saliva antibody-fingerprint of reactivated latent viruses after Mild/Asymptomatic COVID-19 is unique in patients with myalgic-Encephalomyelitis/Chronic fatigue syndrome. Front Immunol (2022) 13:949787/BIBTEX. doi:&#xa0;10.3389/FIMMU.2022.949787/BIBTEX</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FIMMU.2022.949787/BIBTEX</ArticleId><ArticleId IdType="pmc">PMC9630598</ArticleId><ArticleId IdType="pubmed">36341457</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes E, Wist J, Masuda R, Lodge S, Nitschke P, Kimhofer T, et al. . Incomplete systemic recovery and metabolic phenoreversion in post-Acute-Phase nonhospitalized COVID-19 patients: implications for assessment of post-acute COVID-19 syndrome. J Proteome Res (2021) 20:3315&#x2013;29. doi:&#xa0;10.1021/ACS.JPROTEOME.1C00224/ASSET/IMAGES/LARGE/PR1C00224_0007.JPEG</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ACS.JPROTEOME.1C00224/ASSET/IMAGES/LARGE/PR1C00224_0007.JPEG</ArticleId><ArticleId IdType="pubmed">34009992</ArticleId></ArticleIdList></Reference><Reference><Citation>Guarnieri JW, Dybas JM, Fazelinia H, Kim MS, Frere J, Zhang Y, et al. . Targeted down regulation of core mitochondrial genes during SARS-CoV-2 infection. bioRxiv (2022). [Preprint]. doi:&#xa0;10.1101/2022.02.19.481089</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.02.19.481089</ArticleId></ArticleIdList></Reference><Reference><Citation>Snider JM, You JK, Wang X, Snider AJ, Hallmark B, Zec MM, et al. . Group IIA secreted phospholipase A2 is associated with the pathobiology leading to COVID-19 mortality. J Clin Invest (2021) 131(19). doi:&#xa0;10.1172/JCI149236</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI149236</ArticleId><ArticleId IdType="pmc">PMC8483752</ArticleId><ArticleId IdType="pubmed">34428181</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood E, Hall KH, Tate W. Role of mitochondria, oxidative stress and the response to antioxidants in myalgic Encephalomyelitis/Chronic fatigue syndrome: a possible approach to SARS-CoV-2 &#x201c;Long-haulers&#x201d;? Chronic Dis Transl Med (2021) 7:14&#x2013;26. doi:&#xa0;10.1016/J.CDTM.2020.11.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.CDTM.2020.11.002</ArticleId><ArticleId IdType="pmc">PMC7680046</ArticleId><ArticleId IdType="pubmed">33251031</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajaz S, McPhail MJ, Singh KK, Mujib S, Trovato FM, Napoli S, et al. . Mitochondrial metabolic manipulation by SARS-CoV-2 in peripheral blood mononuclear cells of patients with COVID-19. Am J Physiol Cell Physiol (2021) 320:C57&#x2013;65. doi:&#xa0;10.1152/AJPCELL.00426.2020/ASSET/IMAGES/LARGE/AJ-ACEL200031F005.JPEG</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/AJPCELL.00426.2020/ASSET/IMAGES/LARGE/AJ-ACEL200031F005.JPEG</ArticleId><ArticleId IdType="pmc">PMC7816428</ArticleId><ArticleId IdType="pubmed">33151090</ArticleId></ArticleIdList></Reference><Reference><Citation>Allali I, Bakri Y, Amzazi S, Ghazal H. Gut-lung axis in COVID-19. Interdiscip Perspect Infect Dis (2021) 2021:202. doi:&#xa0;10.1155/2021/6655380</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/6655380</ArticleId><ArticleId IdType="pmc">PMC7979298</ArticleId><ArticleId IdType="pubmed">33777139</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannos P, Prokopidis K. Gut dysbiosis and long COVID-19: feeling gutted. J Med Virol (2022) 94:2917. doi:&#xa0;10.1002/JMV.27684</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JMV.27684</ArticleId><ArticleId IdType="pmc">PMC9088471</ArticleId><ArticleId IdType="pubmed">35233795</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Q, Lau RI, Liu Q, Chan FKL, Ng SC. Post-acute COVID-19 syndrome and gut dysbiosis linger beyond 1 year after SARS-CoV-2 clearance. Gut (2022). doi:&#xa0;10.1136/GUTJNL-2022-328319</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/GUTJNL-2022-328319</ArticleId><ArticleId IdType="pubmed">35940857</ArticleId></ArticleIdList></Reference><Reference><Citation>Haran JP, Bradley E, Zeamer AL, Cincotta L, Salive MC, Dutta P, et al. . Inflammation-type dysbiosis of the oral microbiome associates with the duration of COVID-19 symptoms and long COVID. JCI Insight (2021) 6(20). doi:&#xa0;10.1172/jci.insight.152346</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.152346</ArticleId><ArticleId IdType="pmc">PMC8564890</ArticleId><ArticleId IdType="pubmed">34403368</ArticleId></ArticleIdList></Reference><Reference><Citation>Giron LB, Peluso MJ, Ding J, Kenny G, Zilberstein NF, Koshy J, et al. . Markers of fungal translocation are elevated during post-acute sequelae of SARS-CoV-2 and induce NF-KB signaling. JCI Insight (2022) 7(15). doi:&#xa0;10.1172/jci.insight.160989</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.160989</ArticleId><ArticleId IdType="pmc">PMC9462470</ArticleId><ArticleId IdType="pubmed">35727635</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson CB, Farzan M, Chen B, Choe H. Mechanisms of SARS-CoV-2 entry into cells. Nat Rev Mol Cell Biol (2021) 23(1):3&#x2013;20. doi:&#xa0;10.1038/s41580-021-00418-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-021-00418-x</ArticleId><ArticleId IdType="pmc">PMC8491763</ArticleId><ArticleId IdType="pubmed">34611326</ArticleId></ArticleIdList></Reference><Reference><Citation>Schweighauser M, Arseni D, Bacioglu M, Huang M, L&#xf6;vestam S, Shi Y, et al. . Age-dependent formation of TMEM106B amyloid filaments in human brains. Nature (2022) 605:310&#x2013;4. doi:&#xa0;10.1038/S41586-022-04650-Z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41586-022-04650-Z</ArticleId><ArticleId IdType="pmc">PMC9095482</ArticleId><ArticleId IdType="pubmed">35344985</ArticleId></ArticleIdList></Reference><Reference><Citation>Nystr&#xf6;m S, Hammarstr&#xf6;m P. Amyloidogenesis of SARS-CoV-2 spike protein. bioRxiv (2021) 2021:472920. doi:&#xa0;10.1101/2021.12.16.472920</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.12.16.472920</ArticleId><ArticleId IdType="pmc">PMC9136918</ArticleId><ArticleId IdType="pubmed">35579205</ArticleId></ArticleIdList></Reference><Reference><Citation>Kavi L. Postural tachycardia syndrome and long COVID: an update. Br J Gen Pract (2022) 72:8&#x2013;9. doi:&#xa0;10.3399/BJGP22X718037</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/BJGP22X718037</ArticleId><ArticleId IdType="pmc">PMC8714530</ArticleId><ArticleId IdType="pubmed">34972793</ArticleId></ArticleIdList></Reference><Reference><Citation>Chadda KR, Blakey EE, Huang CLH, Jeevaratnam K. Long COVID-19 and postural orthostatic tachycardia SyndromeIs dysautonomia to be blamed? Front Cardiovasc Med (2022) 9:860198/XML/NLM. doi:&#xa0;10.3389/FCVM.2022.860198/XML/NLM</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FCVM.2022.860198/XML/NLM</ArticleId><ArticleId IdType="pmc">PMC8959615</ArticleId><ArticleId IdType="pubmed">35355961</ArticleId></ArticleIdList></Reference><Reference><Citation>Dani M, Dirksen A, Taraborrelli P, Torocastro M, Panagopoulos D, Sutton R, et al. . Autonomic dysfunction in &#x2018;Long COVID&#x2019;: rationale, physiology and management strategies. Clin Med (2021) 21:e63. doi:&#xa0;10.7861/CLINMED.2020-0896</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/CLINMED.2020-0896</ArticleId><ArticleId IdType="pmc">PMC7850225</ArticleId><ArticleId IdType="pubmed">33243837</ArticleId></ArticleIdList></Reference><Reference><Citation>
World Health Organization . A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021. Available at: https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1 (Accessed 3 June 2022).</Citation></Reference><Reference><Citation>Bowe B, Xie Y, Al-Aly Z. Acute and postacute sequelae associated with SARS-CoV-2 reinfection. Nature medicine (2022) 10:1&#x2013;8. doi:&#xa0;10.1038/s41591-022-02051-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02051-3</ArticleId><ArticleId IdType="pmc">PMC9671810</ArticleId><ArticleId IdType="pubmed">36357676</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering A, van Zon SKR, olde Hartman TC, Rosmalen JGM. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet (2022) 400:452&#x2013;61. doi:&#xa0;10.1016/S0140-6736(22)01214-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01214-4</ArticleId><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans RA, Leavy OC, Richardson M, Elneima O, McAuley HJC, Shikotra A, et al. . Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study. Lancet Respir Med (2022) 10:761&#x2013;75. doi:&#xa0;10.1016/S2213-2600(22)00127-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00127-8</ArticleId><ArticleId IdType="pmc">PMC9034855</ArticleId><ArticleId IdType="pubmed">35472304</ArticleId></ArticleIdList></Reference><Reference><Citation>Bungenberg J, Humkamp K, Hohenfeld C, Rust MI, Ermis U, Dreher M, et al. . Long COVID-19: objectifying most self-reported neurological symptoms. Ann Clin Transl Neurol (2022) 9:141&#x2013;54. doi:&#xa0;10.1002/ACN3.51496</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ACN3.51496</ArticleId><ArticleId IdType="pmc">PMC8862437</ArticleId><ArticleId IdType="pubmed">35060361</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackay A. A paradigm for post-Covid-19 fatigue syndrome analogous to ME/CFS. Front Neurol (2021) 12:701419/BIBTEX. doi:&#xa0;10.3389/FNEUR.2021.701419/BIBTEX</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FNEUR.2021.701419/BIBTEX</ArticleId><ArticleId IdType="pmc">PMC8365156</ArticleId><ArticleId IdType="pubmed">34408721</ArticleId></ArticleIdList></Reference><Reference><Citation>Calabria M, Garc&#xed;a-S&#xe1;nchez C, Grunden N, Pons C, Arroyo JA, G&#xf3;mez-Anson B, et al. . Post-COVID-19 fatigue: the contribution of cognitive and neuropsychiatric symptoms. J Neurol (2022) 269:3990&#x2013;9. doi:&#xa0;10.1007/S00415-022-11141-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S00415-022-11141-8</ArticleId><ArticleId IdType="pmc">PMC9055007</ArticleId><ArticleId IdType="pubmed">35488918</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Yao Q, Gu X, Wang Q, Ren L, Wang Y, et al. . 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet (2021) 398:747&#x2013;58. doi:&#xa0;10.1016/S0140-6736(21)01755-4/ATTACHMENT/5440AE6D-9DED-4100-8EE6-77F72BA95154/MMC1.PDF</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01755-4/ATTACHMENT/5440AE6D-9DED-4100-8EE6-77F72BA95154/MMC1.PDF</ArticleId><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Myall KJ, Mukherjee B, Castanheira AM, Lam JL, Benedetti G, Mak SM, et al. . Persistent post-COVID-19 interstitial lung disease. an observational study of corticosteroid treatment. Ann Am Thorac Soc (2021) 18:799&#x2013;806. doi:&#xa0;10.1513/ANNALSATS.202008-1002OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/ANNALSATS.202008-1002OC</ArticleId><ArticleId IdType="pmc">PMC8086530</ArticleId><ArticleId IdType="pubmed">33433263</ArticleId></ArticleIdList></Reference><Reference><Citation>Culebras M, Loor K, Sansano I, Persiva &#xd3;., Clofent D, Polverino E, et al. . Histological findings in transbronchial cryobiopsies obtained from patients after COVID-19. Chest (2022) 161:647&#x2013;50. doi:&#xa0;10.1016/J.CHEST.2021.09.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.CHEST.2021.09.016</ArticleId><ArticleId IdType="pmc">PMC8464080</ArticleId><ArticleId IdType="pubmed">34582842</ArticleId></ArticleIdList></Reference><Reference><Citation>Matheson AM, McIntosh MJ, Kooner HK, Lee J, Desaigoudar V, Bier E, et al. . Persistent 129 xe MRI pulmonary and CT vascular abnormalities in symptomatic individuals with post-acute COVID-19 syndrome. Radiology (2022) 305(2):466&#x2013;76. doi:&#xa0;10.1148/radiol.220492</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.220492</ArticleId><ArticleId IdType="pmc">PMC9272782</ArticleId><ArticleId IdType="pubmed">35762891</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re&#x2019;em Y, et al. . Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine (2021) 38:101019. doi:&#xa0;10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Dryden M, Mudara C, Vika C, Blumberg L, Mayet N, Cohen C, et al. . Post-COVID-19 condition 3 months after hospitalisation with SARS-CoV-2 in south Africa: a prospective cohort study. Lancet Glob Health (2022) 10:e1247&#x2013;56. doi:&#xa0;10.1016/S2214-109X(22)00286-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2214-109X(22)00286-8</ArticleId><ArticleId IdType="pmc">PMC9363040</ArticleId><ArticleId IdType="pubmed">35961348</ArticleId></ArticleIdList></Reference><Reference><Citation>Arany&#xf3; J, Bazan V, Llad&#xf3;s G, Dominguez MJ, Bisbal F, Massanella M, et al. . Inappropriate sinus tachycardia in post-Covid-19 syndrome. Scientific Reports (2022) 12(1):298. doi:&#xa0;10.1038/s41598-021-03831-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-03831-6</ArticleId><ArticleId IdType="pmc">PMC8741896</ArticleId><ArticleId IdType="pubmed">34996973</ArticleId></ArticleIdList></Reference><Reference><Citation>St&#xe5;hlberg M, Reistam U, Fedorowski A, Villacorta H, Horiuchi Y, Bax J, et al. . Post-COVID-19 tachycardia syndrome: a distinct phenotype of post-acute COVID-19 syndrome. Am J Med (2021) 134:1451&#x2013;6. doi:&#xa0;10.1016/j.amjmed.2021.07.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2021.07.004</ArticleId><ArticleId IdType="pmc">PMC8356730</ArticleId><ArticleId IdType="pubmed">34390682</ArticleId></ArticleIdList></Reference><Reference><Citation>Roca-Fernandez A, Wamil M, Telford A, Carapella V, Thomaides-Brears H, Dennis A, et al. . Cardiovascular impairment in long COVID one year post-SARS-COV-2 infection. J Am Coll Cardiol (2022) 79:1312. doi:&#xa0;10.1016/S0735-1097(22)02303-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0735-1097(22)02303-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi H, Zuo Y, Navaz S, Harbaugh A, Hoy CK, Gandhi AA, et al. . Endothelial cell-activating antibodies in COVID-19. medRxiv (2022) 74(7):1132&#x2013;8. doi:&#xa0;10.1101/2021.01.18.21250041</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.01.18.21250041</ArticleId><ArticleId IdType="pmc">PMC9082472</ArticleId><ArticleId IdType="pubmed">35174669</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein SR, Ramelli SC, Grazioli A, Chung JY, Singh M, Yinda CK, et al. . SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature (2022) 612(7941):758&#x2013;63. doi:&#xa0;10.1038/s41586-022-05542-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05542-y</ArticleId><ArticleId IdType="pmc">PMC9749650</ArticleId><ArticleId IdType="pubmed">36517603</ArticleId></ArticleIdList></Reference><Reference><Citation>Camaz&#xf3;n NV, Teis A, Membrive MJM, Llibre C, Bay&#xe9;s-Gen&#xed;s A, Mateu L. Long COVID-19 and microvascular disease-related angina. Rev Esp Cardiol (Engl Ed) (2022) 75:444. doi:&#xa0;10.1016/J.REC.2021.10.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.REC.2021.10.010</ArticleId><ArticleId IdType="pmc">PMC8552551</ArticleId><ArticleId IdType="pubmed">34824040</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamed MO, Banerjee A. Long COVID and cardiovascular disease: a learning health system approach. Nat Rev Cardiol (2022) 19(5):287&#x2013;8. doi:&#xa0;10.1038/s41569-022-00697-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-022-00697-7</ArticleId><ArticleId IdType="pmc">PMC8943785</ArticleId><ArticleId IdType="pubmed">35332308</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo Y, Yalavarthi S, Navaz S, Hoy C, Harbaugh A, Gockman K, et al. . Autoantibodies stabilize neutrophil extracellular traps in COVID-19. JCI Insight (2021) 6(15):e150111. doi:&#xa0;10.1172/jci.insight.150111</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.150111</ArticleId><ArticleId IdType="pmc">PMC8410057</ArticleId><ArticleId IdType="pubmed">34166229</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsoularis I, Fonseca-Rodr&#xed;guez O, Farrington P, Jerndal H, Lundevaller EH, Sund M, et al. . Risks of deep vein thrombosis, pulmonary embolism, and bleeding after covid-19: nationwide self-controlled cases series and matched cohort study. BMJ (2022) 377:e069590. doi:&#xa0;10.1136/BMJ-2021-069590</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/BMJ-2021-069590</ArticleId><ArticleId IdType="pmc">PMC8984137</ArticleId><ArticleId IdType="pubmed">35387772</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight R, Walker V, Ip S, Cooper JA, Bolton T, Keene S, et al. . Association of COVID-19 with major arterial and venous thrombotic diseases: a population-wide cohort study of 48 million adults in England and Wales. Circulation (2022) 146:892&#x2013;906. doi:&#xa0;10.1161/CIRCULATIONAHA.122.060785</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.122.060785</ArticleId><ArticleId IdType="pmc">PMC9484653</ArticleId><ArticleId IdType="pubmed">36121907</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Casta&#xf1;eda A, Lu P, Geraghty AC, Song E, Lee M-H, Wood J, et al. . Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation. Cell (2022) 185:2452&#x2013;68.e16. doi:&#xa0;10.1016/J.CELL.2022.06.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.CELL.2022.06.008</ArticleId><ArticleId IdType="pmc">PMC9189143</ArticleId><ArticleId IdType="pubmed">35768006</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, Lee S, Alfaro-Almagro F, Arthofer C, Wang C, McCarthy P, et al. . SARS-CoV-2 is associated with changes in brain structure in UK biobank. Nature (2022) 604(7907):697&#x2013;707. doi:&#xa0;10.1038/s41586-022-04569-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampshire A, Chatfield DA, MPhil AM, Jolly A, Trender W, Hellyer PJ, et al. . Multivariate profile and acute-phase correlates of cognitive deficits in a COVID-19 hospitalised cohort. EClinicalMedicine (2022) 47:101417. doi:&#xa0;10.1016/j.eclinm.2022.101417</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101417</ArticleId><ArticleId IdType="pmc">PMC9048584</ArticleId><ArticleId IdType="pubmed">35505938</ArticleId></ArticleIdList></Reference><Reference><Citation>Song E, Bartley CM, Chow RD, Ngo TT, Jiang R, Zamecnik CR, et al. . Divergent and self-reactive immune responses in the CNS of COVID-19 patients with neurological symptoms. Cell Rep Med (2021) 2(5):100288. doi:&#xa0;10.1016/j.xcrm.2021.100288</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2021.100288</ArticleId><ArticleId IdType="pmc">PMC8091032</ArticleId><ArticleId IdType="pubmed">33969321</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartley CM, Johns C, Ngo TT, Dandekar R, Loudermilk RL, Alvarenga BD, et al. . Anti-SARS-CoV-2 and autoantibody profiles in the cerebrospinal fluid of 3 teenaged patients with COVID-19 and subacute neuropsychiatric symptoms. JAMA Neurol (2021) 78:1503&#x2013;9. doi:&#xa0;10.1001/JAMANEUROL.2021.3821</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/JAMANEUROL.2021.3821</ArticleId><ArticleId IdType="pmc">PMC8546622</ArticleId><ArticleId IdType="pubmed">34694339</ArticleId></ArticleIdList></Reference><Reference><Citation>Merikanto I, Dauvilliers Y, Chung F, Wing YK, de Gennaro L, Holzinger B, et al. . Sleep symptoms are essential features of long-COVID - comparing healthy controls with COVID-19 cases of different severity in the international COVID sleep study (ICOSS-II). J Sleep Res (2022) 32(1):e13754. doi:&#xa0;10.1111/jsr.13754</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jsr.13754</ArticleId><ArticleId IdType="pmc">PMC9874584</ArticleId><ArticleId IdType="pubmed">36208038</ArticleId></ArticleIdList></Reference><Reference><Citation>Badenoch JB, Rengasamy ER, Watson C, Jansen K, Chakraborty S, Sundaram RD, et al. . Persistent neuropsychiatric symptoms after COVID-19: a systematic review and meta-analysis. Brain Commun (2022) 4(1):fcab297. doi:&#xa0;10.1093/braincomms/fcab297</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcab297</ArticleId><ArticleId IdType="pmc">PMC8833580</ArticleId><ArticleId IdType="pubmed">35169700</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu E, Xie Y, Al-Aly Z. Long-term neurological sequelae of SARS-CoV-2 infection. Nat Med (2022) 2022:1&#x2013;2. doi:&#xa0;10.1038/s41591-022-02018-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02018-4</ArticleId><ArticleId IdType="pmc">PMC9528864</ArticleId><ArticleId IdType="pubmed">36192556</ArticleId></ArticleIdList></Reference><Reference><Citation>Ignatova D, Krasteva K, Akabalieva K, Alexiev S. Post-COVID-19 psychosis: cotard&#x2019;s syndrome and potentially high risk of harm and self-harm in a first-onset acute and transient psychotic disorder after resolution of COVID-19 pneumonia. Early Interv Psychiatry (2022) 16(10):1159&#x2013;62. doi:&#xa0;10.1111/eip.13254</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eip.13254</ArticleId><ArticleId IdType="pmc">PMC8653068</ArticleId><ArticleId IdType="pubmed">34796667</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasnier M, Choucha W, Radiguer F, Faulet T, Chappell K, Bougarel A, et al. . Comorbidity of long COVID and psychiatric disorders after a hospitalisation for COVID-19: a cross-sectional study. J Neurol Neurosurg Psychiatry (2022) 0:1&#x2013;8. doi:&#xa0;10.1136/JNNP-2021-328516</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/JNNP-2021-328516</ArticleId><ArticleId IdType="pubmed">35953265</ArticleId></ArticleIdList></Reference><Reference><Citation>Meringer H, Mehandru S. Gastrointestinal post-acute COVID-19 syndrome. Nat Rev Gastroenterol Hepatol (2022) 19(6):345&#x2013;6. doi:&#xa0;10.1038/s41575-022-00611-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41575-022-00611-z</ArticleId><ArticleId IdType="pmc">PMC8981882</ArticleId><ArticleId IdType="pubmed">35383321</ArticleId></ArticleIdList></Reference><Reference><Citation>Rafiqul Islam SM, Foysal MJ, Hoque MN, Mehedi HMH, Rob MA, Salauddin A, et al. . Dysbiosis of oral and gut microbiomes in SARS-CoV-2 infected patients in Bangladesh: elucidating the role of opportunistic gut microbes. Front Med (Lausanne) (2022) 9:821777/FULL. doi:&#xa0;10.3389/FMED.2022.821777/FULL</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FMED.2022.821777/FULL</ArticleId><ArticleId IdType="pmc">PMC8882723</ArticleId><ArticleId IdType="pubmed">35237631</ArticleId></ArticleIdList></Reference><Reference><Citation>Stokel-Walker C. How long does SARS-CoV-2 stay in the body? BMJ (2022) 377:o1555. doi:&#xa0;10.1136/BMJ.O1555</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/BMJ.O1555</ArticleId><ArticleId IdType="pubmed">35764342</ArticleId></ArticleIdList></Reference><Reference><Citation>Karaarslan F, G&#xfc;neri FD, Karde&#x15f; S. Long COVID: Rheumatologic/Musculoskeletal symptoms in hospitalized COVID-19 survivors at 3 and 6 months. Clin Rheumatol (2022) 41:289&#x2013;96. doi:&#xa0;10.1007/S10067-021-05942-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S10067-021-05942-X</ArticleId><ArticleId IdType="pmc">PMC8553494</ArticleId><ArticleId IdType="pubmed">34713356</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan C, Lim R, Yeow M, Fong J, Balakrishnan T. Tietze&#x2019;s syndrome post-COVID-19 infection in an adult patient. Cureus (2022) 14(7). doi:&#xa0;10.7759/cureus.27499</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.27499</ArticleId><ArticleId IdType="pmc">PMC10564091</ArticleId><ArticleId IdType="pubmed">37817896</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins RA, Ray N, Ratheal K, Colon A. Severe post-COVID-19 costochondritis in children. Proc (Bayl Univ Med Cent) (2022) 35:56. doi:&#xa0;10.1080/08998280.2021.1973274</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08998280.2021.1973274</ArticleId><ArticleId IdType="pmc">PMC8477585</ArticleId><ArticleId IdType="pubmed">34966216</ArticleId></ArticleIdList></Reference><Reference><Citation>Sapkota HR, Nune A. Long COVID from rheumatology perspective &#x2014; a narrative review. Clin Rheumatol (2022) 41:337. doi:&#xa0;10.1007/S10067-021-06001-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S10067-021-06001-1</ArticleId><ArticleId IdType="pmc">PMC8629735</ArticleId><ArticleId IdType="pubmed">34845562</ArticleId></ArticleIdList></Reference><Reference><Citation>McMahon DE, Gallman AE, Hruza GJ, Rosenbach M, Lipoff JB, Desai SR, et al. . Long COVID in the skin: a registry analysis of COVID-19 dermatological duration. Lancet Infect Dis (2021) 21:313. doi:&#xa0;10.1016/S1473-3099(20)30986-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30986-5</ArticleId><ArticleId IdType="pmc">PMC7836995</ArticleId><ArticleId IdType="pubmed">33460566</ArticleId></ArticleIdList></Reference><Reference><Citation>Andr&#xe9; R, Hsieh A, Trellu LT. Chronic acral lesions (&#x201c;COVID toes&#x201d;): to add to long post- COVID-19 syndrome? Angiology (2022) 73:788&#x2013;9. doi:&#xa0;10.1177/00033197211068938/ASSET/IMAGES/LARGE/10.1177_00033197211068938-FIG1.JPEG</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/00033197211068938/ASSET/IMAGES/LARGE/10.1177_00033197211068938-FIG1.JPEG</ArticleId><ArticleId IdType="pmc">PMC9411688</ArticleId><ArticleId IdType="pubmed">34979814</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Khunti K, Nafilyan V, Maddox T, Humberstone B, Diamond I, et al. . Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ (2021) 372:n693. doi:&#xa0;10.1136/BMJ.N693</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/BMJ.N693</ArticleId><ArticleId IdType="pmc">PMC8010267</ArticleId><ArticleId IdType="pubmed">33789877</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A, Cuthbertson DJ, Wootton D, Crooks M, Gabbay M, Eichert N, et al. . Multi-organ impairment and long COVID: a 1-year prospective, longitudinal cohort study. medRxiv (2022) 2022:3. doi:&#xa0;10.1101/2022.03.18.22272607</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.03.18.22272607</ArticleId><ArticleId IdType="pmc">PMC10041626</ArticleId><ArticleId IdType="pubmed">36787802</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Al-Aly Z. Risks and burdens of incident diabetes in long COVID: a cohort study. Lancet Diabetes Endocrinol (2022) 10:311&#x2013;21. doi:&#xa0;10.1016/S2213-8587(22)00044-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(22)00044-4</ArticleId><ArticleId IdType="pmc">PMC8937253</ArticleId><ArticleId IdType="pubmed">35325624</ArticleId></ArticleIdList></Reference><Reference><Citation>Yende S, Parikh CR. Long COVID and kidney disease. Nat Rev Nephrol (2021) 17(12):792&#x2013;3. doi:&#xa0;10.1038/s41581-021-00487-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41581-021-00487-3</ArticleId><ArticleId IdType="pmc">PMC8427150</ArticleId><ArticleId IdType="pubmed">34504319</ArticleId></ArticleIdList></Reference><Reference><Citation>Fierro NA. COVID-19 and the liver: what do we know after six months of the pandemic? Ann Hepatol (2020) 19:590&#x2013;1. doi:&#xa0;10.1016/J.AOHEP.2020.09.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.AOHEP.2020.09.001</ArticleId><ArticleId IdType="pmc">PMC7500273</ArticleId><ArticleId IdType="pubmed">32956871</ArticleId></ArticleIdList></Reference><Reference><Citation>Roth NC, Kim A, Vitkovski T, Xia J, Ramirez G, Bernstein D, et al. . Post-COVID-19 cholangiopathy: a novel entity. Am J Gastroenterol (2021) 116:1077&#x2013;82. doi:&#xa0;10.14309/AJG.0000000000001154</Citation><ArticleIdList><ArticleId IdType="doi">10.14309/AJG.0000000000001154</ArticleId><ArticleId IdType="pubmed">33464757</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Penfold RS, Merino J, Sudre CH, Molteni E, Berry S, et al. . Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID symptom study app: a prospective, community-based, nested, case-control study. Lancet Infect Dis (2022) 22:43&#x2013;55. doi:&#xa0;10.1016/S1473-3099(21)00460-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00460-6</ArticleId><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzolini E, Levi R, Sarti R, Pozzi C, Mollura M, Mantovani A, et al. . Association between BNT162b2 vaccination and long COVID after infections not requiring hospitalization in health care workers. JAMA (2022) 328:676&#x2013;8. doi:&#xa0;10.1001/JAMA.2022.11691</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/JAMA.2022.11691</ArticleId><ArticleId IdType="pmc">PMC9250078</ArticleId><ArticleId IdType="pubmed">35796131</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao P, Liu J, Liu M. Effect of COVID-19 vaccines on reducing the risk of long COVID in the real world: a systematic review and meta-analysis. Int J Environ Res Public Health (2022) 19(19):12422. doi:&#xa0;10.3390/ijerph191912422</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph191912422</ArticleId><ArticleId IdType="pmc">PMC9566528</ArticleId><ArticleId IdType="pubmed">36231717</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Bermingham C, Pouwels KB, Glickman M, Nafilyan V, Zaccardi F, et al. . Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study. BMJ (2022) 377:e069676. doi:&#xa0;10.1136/bmj-2021-069676</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-069676</ArticleId><ArticleId IdType="pmc">PMC9115603</ArticleId><ArticleId IdType="pubmed">35584816</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>